These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 7716703)
21. Cytokines in systemic lupus erythematosus. Poole BD; Niewold TB; Tsokos GC; Via CS J Biomed Biotechnol; 2010; 2010():735169. PubMed ID: 21603232 [No Abstract] [Full Text] [Related]
22. Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Suh CH; Kim HA Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305 [TBL] [Abstract][Full Text] [Related]
23. Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction. Moore PM; Lisak RP Springer Semin Immunopathol; 1995; 17(1):43-60. PubMed ID: 7482226 [TBL] [Abstract][Full Text] [Related]
24. Tumour necrosis factor and other cytokines in murine lupus. Theofilopoulos AN; Lawson BR Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I49-55. PubMed ID: 10577973 [No Abstract] [Full Text] [Related]
25. T helper cell subsets in the pathogenesis of systemic lupus erythematosus. Reininger L; Santiago ML; Takahashi S; Fossati L; Izui S Ann Med Interne (Paris); 1996; 147(7):467-71. PubMed ID: 9092356 [TBL] [Abstract][Full Text] [Related]
26. DNA as a marker of cell death in systemic lupus erythematosus. Pisetsky DS Rheum Dis Clin North Am; 2004 Aug; 30(3):575-87, x. PubMed ID: 15261342 [TBL] [Abstract][Full Text] [Related]
27. [Physiopathology of systemic lupus erythematosus: a 2014 update]. Mathian A; Arnaud L; Amoura Z Rev Med Interne; 2014 Aug; 35(8):503-11. PubMed ID: 24262408 [TBL] [Abstract][Full Text] [Related]
30. The roles of interleukin-6 and interleukin-10 in B cell hyperactivity in systemic lupus erythematosus. Cross JT; Benton HP Inflamm Res; 1999 May; 48(5):255-61. PubMed ID: 10391113 [TBL] [Abstract][Full Text] [Related]
31. New biologic therapy for systemic lupus erythematosus. Ding HJ; Gordon C Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092 [TBL] [Abstract][Full Text] [Related]
32. Cytokines and systemic lupus erythematosus. Dean GS; Tyrrell-Price J; Crawley E; Isenberg DA Ann Rheum Dis; 2000 Apr; 59(4):243-51. PubMed ID: 10733469 [No Abstract] [Full Text] [Related]
33. Systemic lupus erythematosus and atherosclerosis: Review of the literature. Frieri M; Stampfl H Autoimmun Rev; 2016 Jan; 15(1):16-21. PubMed ID: 26299985 [TBL] [Abstract][Full Text] [Related]
34. Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression. Sthoeger ZM; Sharabi A; Molad Y; Asher I; Zinger H; Dayan M; Mozes E J Autoimmun; 2009 Aug; 33(1):77-82. PubMed ID: 19346102 [TBL] [Abstract][Full Text] [Related]
38. The role of inflammation in cancer and systemic lupus erythematosus. Rinaldi I Acta Med Indones; 2013 Jul; 45(3):167-9. PubMed ID: 24045384 [No Abstract] [Full Text] [Related]
39. Methyl salicylate 2- He YY; Yan Y; Zhang HF; Lin YH; Chen YC; Yan Y; Wu P; Fang JS; Yang SH; Du GH Drug Des Devel Ther; 2016; 10():3183-3196. PubMed ID: 27729775 [TBL] [Abstract][Full Text] [Related]